Inactive Instrument

VPCL Limited Stock

VPC

AU000000VPC3

Health House International Limited, formerly VPCL Ltd, is an Australia-based International distributor of medicinal cannabis. The Company is principally engaged in acquiring locally-produced medicinal cannabis products and also imports medicinal cannabis from Canada, Germany, Netherlands, Macedonia, Slovenia, the United Kingdom (UK) and the United States of America (USA) and wholesales direct to Australian pharmacies, hospitals and researchers. It holds a number of strategic licenses to store, distribute, import, export and wholesale controlled drugs. The Company distributes various products, which includes iX Biopharma, ZELIRA Therapeutics, Ananda Hemp, Little Green Pharma, ANTG, HAPA and Satipharm.

Employees

Sector

Pharmaceuticals

More about the company

19/03/23	Certain Ordinary Shares of VPCL Limited are subject to a Lock-Up Agreement Ending on 19-MAR-2023.	CI
19/03/22	48,151,685 Ordinary Shares of VPCL Limited are subject to a Lock-Up Agreement Ending on 19-MAR-2022.	CI
09/10/21	5,740,255 Ordinary Shares of VPCL Limited are subject to a Lock-Up Agreement Ending on 9-OCT-2021.	CI
19/03/21	VPCL : Completes Acquisition of Health House	MT
19/03/21	Health House Holdings Limited completed the acquisition of VPCL Limited in a reverse merger transaction	CI
17/03/21	VPCL : Received Conditional Approval to Reinstate Shares on Aussie Bourse	MT
01/03/21	Vpcl Limited Reports Earnings Results for the Half Year Ended December 31, 2020	CI
24/11/20	VPCL : Buys Cannabis Distribution Business	MT
24/11/20	Health House Holdings Limited entered into a binding heads of agreement to acquire VPCL Limited in a reverse merger transaction	CI
31/08/20	Vpcl Limited Reports Earnings Results for the Full Year Ended June 30, 2020	CI
03/04/20	VPCL Limited Announces Board Changes	CI
28/02/20	VPCL Limited Reports Earnings Results for the Half Year Ended December 31, 2019	CI
30/08/19	Vpcl Limited Reports Earnings Results for the Full Year Ended June 30, 2019	CI

25/08/17	Velpic : Appendix 4E and Annual Report to Shareholders	PU
02/08/17	Velpic : Launches eCoaching Platform – Velpic Sport	PU
11/07/17	Velpic : expands its distribution network in the US	PU
16/05/17	Velpic : Awarded Industry Accolade and Adds New Features	PU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VPCL LIMITED	-.--%	-.--%	-	-	3.5M
ELI LILLY AND COMPANY	+0.35%	+1.36%	+45.38%	+140.47%	1,280B
JOHNSON & JOHNSON	-0.13%	+1.48%	+44.67%	+90.43%	675B
ABBVIE INC.	+0.37%	+0.05%	+31.00%	+112.84%	521B
ROCHE HOLDING AG	+0.71%	+3.42%	+39.50%	+69.68%	386B
MERCK & CO., INC.	-0.59%	-2.11%	+61.83%	+45.16%	363B
NOVARTIS AG	+1.04%	+0.15%	+28.29%	+58.73%	301B
ASTRAZENECA PLC	+0.65%	-0.21%	+3.65%	+36.73%	286B
AMGEN INC.	+0.62%	-2.17%	+38.31%	+75.12%	253B
GILEAD SCIENCES, INC.	-0.67%	-2.72%	+38.49%	+123.56%	211B
Average	+0.42%	-0.51%	+36.79%	+83.64%	475B
Weighted average by Cap.	+0.65%	+0.20%	+39.63%	+97.33%

VPCL Limited Stock

Stocks

VPC

AU000000VPC3

Pharmaceuticals

Latest news: VPCL Limited

Press Releases: VPCL Limited

Pharmaceuticals Wholesale

Company Profile